FDC, formerly known as FairDeal Corporation, has been in the pharmaceutical business for almost seven decades now.

Firsts
With a modest beginning in 1936 - marketing vitamins and a range of prescription formulations - FDC set up its first formulations manufacturing facility in 1949.

Subsequently, in 1963, FDC pioneered the manufacture of specialized ophthalmic formulations in India.

In 1972, FDC initiated the concept of Oral Rehydration Salts (ORS). Today its brand 'Electral', commands more than 70% market share in this segment, an impressive achievement in a fiercely competitive market. 

FDC's API plant at Roha (Maharashtra) was among the first few API facilities in India to get US-FDA approval in 1984. Since then, FDC has to its credit a number of new molecules, introduced for the first time in the nation.

Products
Besides ORS, FDC was the first to offer soya-based infant foods in India. Today, FDC has a distinct presence in numerous therapeutic segments such as anti-infectives, dermatologicals, respiratory, haematinics, and is the undisputed leader in ORS and ophthalmics.

FDC has earned widespread recognition by virtue of its leading brands viz. Electral, Pyrimon, Zifi and Mycoderm to name a few.

Recognition
FDC received the Quality Excellence Award from "Indian Drug Manufacturers' Association" (IDMA) in 1993 and 1994.

For breakthrough R&D efforts, FDC has been awarded the "National Award for R&D effort in the industry" by the Department of Scientific Affairs, Ministry of Commerce, Govt. of India.

Apart from being WHO-GMP certified, FDC's API and formulation manufacturing facilities are approved by regulatory authorities from all over the globe, including UK MHRA, US FDA, ANVISA (Brazil), and MCC (South Africa).